1. Home
  2. CAC vs MGTX Comparison

CAC vs MGTX Comparison

Compare CAC & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camden National Corporation

CAC

Camden National Corporation

HOLD

Current Price

$50.13

Market Cap

857.1M

Sector

Finance

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$10.66

Market Cap

909.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAC
MGTX
Founded
1875
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
857.1M
909.1M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
CAC
MGTX
Price
$50.13
$10.66
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$47.00
$24.57
AVG Volume (30 Days)
77.4K
617.7K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
3.51%
N/A
EPS Growth
6.08
33.02
EPS
1.29
N/A
Revenue
$41,739,000.00
$81,391,000.00
Revenue This Year
$19.15
$141.38
Revenue Next Year
$6.05
N/A
P/E Ratio
$38.62
N/A
Revenue Growth
16.96
144.57
52 Week Low
$35.00
$5.14
52 Week High
$53.71
$11.85

Technical Indicators

Market Signals
Indicator
CAC
MGTX
Relative Strength Index (RSI) 58.30 64.46
Support Level $47.12 $7.11
Resistance Level $51.57 $11.85
Average True Range (ATR) 1.07 0.43
MACD 0.21 0.05
Stochastic Oscillator 77.44 97.71

Price Performance

Historical Comparison
CAC
MGTX

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: